Insight journal

Life Science Intelligence for Deal Makers
Welcome to Insight Journal, where you can explore a series of articles and posts written by CP analysts that cover recent partnering trends, significant deals, company partnering strategies and therapy forecasts.

These articles have been written not only to give you insights but advice into popular issues such as the top therapeutic areas and companies to partner with, as well as providing opinion on the latest deal talk.

Insight journal is regularly updated with breaking news as it happens and rumours of potential deals. 

CP Insight: Login | More details | Subscription options

Featured insights

Galapagos – Rapidly taking identified targets through to clinical development

July 28, 2014 : biotechnology, oncology, orphan

Galapagos is a clinical stage biotechnology company headquartered in Belgium discovering and developing candidates to phase I/II development. more »

Seattle Genetics: Empowering monoclonal antibodies

July 22, 2014 : ADC, antibody, oncology

Seattle Genetics is a biotech company developing and commercializing antibody-based therapeutics to improve the lives of people living with cancer. more »

Seattle Genetics : Biotech industry partnering activity 2009-2014

July 22, 2014 : antibody, oncology, seattle

Seattle Genetics, a successful big biotech industry headquartered in Seattle, focuses its effort on advancing antibody drug conjugate technology targeted toward cancer treatment. more »

Galapagos: Biotechnology Partnering activity 2009-2014

July 19, 2014 : biotechnology, clinical stage, musculoskeletal, oncology, orphan diseases

Galapagos, a clinical stage biotechnology company in the United States, is a joint venture between Crucell and Tibotec. more »

Spectrum Pharmaceuticals: Partnering activity 2009-2014

July 14, 2014 : neurology, oncology, spectrum, urology

Spectrum Pharmaceuticals, headquartered in the United States, showcases in the top 50 big biotech companies. more »


Company insights

Therapy insights

Technology insights

Deals and alliances insights

Dealtalk Insights

Print Friendly
RSS Feed Linked In Twitter

Latest Tweets